Cardiff Oncology, Inc. revenue breakdown overview

Cardiff Oncology, Inc. revenue for the last year amounted to 488.00 k USD, the most of which — 488.00 k USD — came from its highest performing source at the moment, Novel Therapies for Cancers, the year earlier bringing 386.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Cardiff Oncology, Inc. 488.00 k USD, and the year before that — 386.00 k USD.